SGI:NYSE
Somnigroup International Inc
$65.23
arrow_downward
-1.26%(-0.83) 1D
Aug 17, 11:51:01 AM GMT-4 · USD
search
All symbols
No data
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SGI...
Open
$65.56
High
$66.02
Low
$64.64
Mkt. cap
13.72B
Avg. vol.
2.54M
Volume
379.40K
Dividend
1.04%
Quarterly dividend
$0.17
Ex-dividend date
May 21, 2026
P/E ratio
26.01
52-wk high
$98.56
52-wk low
$60.39
EPS
$2.51
Beta
1.20
Shares outstanding
210.36M
No. of employees
19K
Open
$65.56
High
$66.02
Low
$64.64
Mkt. cap
13.72B
Avg. vol.
2.54M
Volume
379.40K
Dividend
1.04%
Quarterly dividend
$0.17
Ex-dividend date
May 21, 2026
P/E ratio
26.01
52-wk high
$98.56
52-wk low
$60.39
EPS
$2.51
Beta
1.20
Shares outstanding
210.36M
No. of employees
19K
Profile
Somnigroup International Inc. is an American manufacturer of mattresses and bedding products.
The company was formed when Tempur-Pedic International, a manufacturer of memory foam mattresses, acquired its biggest competitor Sealy Corporation in 2012. It is based in Lexington, Kentucky.
In May 2023, Temper Sealy sought to acquire mattress retailer Mattress Firm for a reported $4 billion. However, in July 2024 the deal was blocked by the United States Federal Trade Commission due to concerns about its impact on competition in the space. The company sued the Federal Trade Commission in October to halt the court proceedings and won the case in January 2025, allowing the deal to go through.
The acquisition was finalized in February 2025 and Tempur Sealy changed its name to Somnigroup International Inc. Wikipedia
About Somnigroup International Inc
CEOScott L Thompson
Employees19K
Founded1846
HeadquartersLexington, Kentucky, United States
SectorHousehold
Websitesomnigroup.com
Analyst ratings
Based on 9 analysts giving stock ratings to SGI in the past 3 months
Strong buy
Buy
9
Hold
0
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for SGI in the last 3 months.
Highest
Current $65.23
$100.00 (+53.30%)
Average
$93.67 (+43.60%)
Lowest
$88.00 (+34.91%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Keith Hughes Truist Financial | Buy | Maintained | $100.00 | +53.3% | 08/11/2026 |
Pedro Gil Morgan Stanley | Buy | Maintained | $95.00 | +45.6% | 08/10/2026 |
Rafe Jadrosich Bank of America Securities | Buy | Maintained | - | - | 08/07/2026 |
Bobby Griffin Raymond James | Buy | Maintained | $90.00 | +38% | 08/07/2026 |
Daniel Silverstein UBS | Buy | Reiterated | $94.00 | +44.1% | 08/07/2026 |
Bradley Thomas KeyBanc | Buy | Maintained | - | - | 08/07/2026 |
Peter Keith Piper Sandler | Buy | Reiterated | $95.00 | +45.6% | 08/07/2026 |
Phillip Blee William Blair | Buy | Maintained | - | - | 08/06/2026 |
Unknown Analyst Morgan Stanley | Buy | Initiated | $95.00 | +45.6% | 07/27/2026 |
Jonathan Matuszewski Jefferies | Buy | Reiterated | $88.00 | +34.9% | 06/26/2026 |
Jeff Lick Stephens | Hold | Initiated | $89.00 | +36.4% | 02/10/2026 |
Last report
Aug 6, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$0.58 / $0.58
+0.77%beat
arrow_upward
Revenue / Est. (USD)
1.82B / 1.88B
-3.13%miss
arrow_downward
Fiscal Q2 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 2.12B | 1.87B | 1.80B | 1.82B |
Cost of goods sold | 1.16B | 913.00M | 1.02B | 1.00B |
Cost of revenue | 1.16B | 913.00M | 1.02B | 1.00B |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 641.20M | 534.10M | 595.40M | 618.60M |
Operating expense | 641.20M | 534.10M | 595.40M | 618.60M |
Total operating expenses | 1.80B | 1.45B | 1.61B | 1.62B |
Operating income | 325.90M | 421.30M | 190.20M | 202.90M |
Other non operating income | -400.00K | 13.70M | 8.80M | 5.90M |
EBT including unusual items | 233.90M | 193.70M | 137.30M | 147.80M |
EBT excluding unusual items | 258.70M | 379.50M | 144.60M | 152.90M |
Income tax expense | 56.20M | 52.80M | 33.40M | 37.20M |
Effective tax rate | 24.03% | 27.26% | 24.33% | 25.17% |
Other operating expenses | - | - | - | - |
Net income | 177.40M | 140.80M | 104.20M | 110.90M |
Net profit margin | 8.36% | 7.54% | 5.78% | 6.08% |
Earnings per share | 0.95 | 0.72 | 0.59 | 0.58 |
Interest and investment income | - | - | - | - |
Interest expense | -69.90M | -64.20M | -60.00M | -59.00M |
Net interest expenses | -69.90M | -64.20M | -60.00M | -59.00M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 389.70M | 490.80M | 251.10M | 265.30M |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
AI content may include mistakes. Learn more